241 related articles for article (PubMed ID: 34321100)
1. Distinct signatures of codon and codon pair usage in 32 primary tumor types in the novel database CancerCoCoPUTs for cancer-specific codon usage.
Meyer D; Kames J; Bar H; Komar AA; Alexaki A; Ibla J; Hunt RC; Santana-Quintero LV; Golikov A; DiCuccio M; Kimchi-Sarfaty C
Genome Med; 2021 Jul; 13(1):122. PubMed ID: 34321100
[TBL] [Abstract][Full Text] [Related]
2. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
Zhao H
Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
[TBL] [Abstract][Full Text] [Related]
3. TissueCoCoPUTs: Novel Human Tissue-Specific Codon and Codon-Pair Usage Tables Based on Differential Tissue Gene Expression.
Kames J; Alexaki A; Holcomb DD; Santana-Quintero LV; Athey JC; Hamasaki-Katagiri N; Katneni U; Golikov A; Ibla JC; Bar H; Kimchi-Sarfaty C
J Mol Biol; 2020 May; 432(11):3369-3378. PubMed ID: 31982380
[TBL] [Abstract][Full Text] [Related]
4. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
5. Codon and Codon-Pair Usage Tables (CoCoPUTs): Facilitating Genetic Variation Analyses and Recombinant Gene Design.
Alexaki A; Kames J; Holcomb DD; Athey J; Santana-Quintero LV; Lam PVN; Hamasaki-Katagiri N; Osipova E; Simonyan V; Bar H; Komar AA; Kimchi-Sarfaty C
J Mol Biol; 2019 Jun; 431(13):2434-2441. PubMed ID: 31029701
[TBL] [Abstract][Full Text] [Related]
6. Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
Wong N; Khwaja SS; Baker CM; Gay HA; Thorstad WL; Daly MD; Lewis JS; Wang X
Cancer Med; 2016 Jul; 5(7):1619-28. PubMed ID: 27109697
[TBL] [Abstract][Full Text] [Related]
7. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.
Chandrashekar DS; Bashel B; Balasubramanya SAH; Creighton CJ; Ponce-Rodriguez I; Chakravarthi BVSK; Varambally S
Neoplasia; 2017 Aug; 19(8):649-658. PubMed ID: 28732212
[TBL] [Abstract][Full Text] [Related]
8. Translational efficiency across healthy and tumor tissues is proliferation-related.
Hernandez-Alias X; Benisty H; Schaefer MH; Serrano L
Mol Syst Biol; 2020 Mar; 16(3):e9275. PubMed ID: 32149479
[TBL] [Abstract][Full Text] [Related]
9. Curation of the Pancreatic Ductal Adenocarcinoma Subset of the Cancer Genome Atlas Is Essential for Accurate Conclusions about Survival-Related Molecular Mechanisms.
Peran I; Madhavan S; Byers SW; McCoy MD
Clin Cancer Res; 2018 Aug; 24(16):3813-3819. PubMed ID: 29739787
[No Abstract] [Full Text] [Related]
10. Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.
Metzger-Filho O; Ferreira AR; Jeselsohn R; Barry WT; Dillon DA; Brock JE; Vaz-Luis I; Hughes ME; Winer EP; Lin NU
Oncologist; 2019 Jul; 24(7):e441-e449. PubMed ID: 30518616
[TBL] [Abstract][Full Text] [Related]
11. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
12. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis.
Turashvili G; Bouchal J; Baumforth K; Wei W; Dziechciarkova M; Ehrmann J; Klein J; Fridman E; Skarda J; Srovnal J; Hajduch M; Murray P; Kolar Z
BMC Cancer; 2007 Mar; 7():55. PubMed ID: 17389037
[TBL] [Abstract][Full Text] [Related]
13. Synonymous mutations that regulate translation speed might play a non-negligible role in liver cancer development.
Li Q; Li J; Yu CP; Chang S; Xie LL; Wang S
BMC Cancer; 2021 Apr; 21(1):388. PubMed ID: 33836673
[TBL] [Abstract][Full Text] [Related]
14. ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast.
Ping Z; Siegal GP; Harada S; Eltoum IE; Youssef M; Shen T; He J; Huang Y; Chen D; Li Y; Bland KI; Chang HR; Shen D
Oncotarget; 2016 Dec; 7(49):80655-80663. PubMed ID: 27811364
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of aberrantly expressed methylation‑driven genes in hepatocellular carcinoma: A study based on The Cancer Genome Atlas.
Li J; Chen N; Gong X
Mol Med Rep; 2019 Dec; 20(6):5304-5314. PubMed ID: 31661127
[TBL] [Abstract][Full Text] [Related]
16. Conservation of immune gene signatures in solid tumors and prognostic implications.
Chifman J; Pullikuth A; Chou JW; Bedognetti D; Miller LD
BMC Cancer; 2016 Nov; 16(1):911. PubMed ID: 27871313
[TBL] [Abstract][Full Text] [Related]
17. Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients.
Li X; Tian R; Gao H; Yang Y; Williams BRG; Gantier MP; McMillan NAJ; Xu D; Hu Y; Gao Y
Sci Rep; 2017 Nov; 7(1):16495. PubMed ID: 29184082
[TBL] [Abstract][Full Text] [Related]
18. Identifying potential prognostic biomarkers in head and neck cancer based on the analysis of microRNA expression profiles in TCGA database.
Wang X; Yin Z; Zhao Y; He M; Dong C; Zhong M
Mol Med Rep; 2020 Mar; 21(3):1647-1657. PubMed ID: 32016476
[TBL] [Abstract][Full Text] [Related]
19. Epigenomic and Transcriptomic Characterization of Secondary Breast Cancers.
Graff-Baker AN; Orozco JIJ; Marzese DM; Salomon MP; Hoon DSB; Goldfarb M
Ann Surg Oncol; 2018 Oct; 25(10):3082-3087. PubMed ID: 29956094
[TBL] [Abstract][Full Text] [Related]
20. Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer.
Sun L; Lin Y; Wang G; Zhang L; Hu L; Lu Z
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33439969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
